AI Clinical Decision Support
AI clinical decision support tools provide real-time access to evidence-based guidelines, drug interactions, differential diagnoses, and care recommendations during patient encounters. Modern tools are conversational rather than rule-based, allowing clinicians to ask natural-language questions and receive cited, evidence-backed answers. The best tools integrate with the EHR to surface contextual recommendations based on the active patient.
Top tools for ai clinical decision support
4 toolsGlass Health
Ambient scribe plus clinical decision support in one platform.
Abridge
Generative AI scribe for Epic and large health systems.
Suki AI
Voice-first AI assistant for clinicians.
Tali AI
Hybrid dictation and AI scribe for primary care.
Related searches
- AI clinical decision support
- AI for diagnosis assistance
- AI medical reference
- evidence-based AI tools
- clinical AI assistant
- AI differential diagnosis
- medical AI knowledge tool
AI Clinical Decision Support: guides and analysis
Glass Health Review 2026: An AI Scribe With a Differential Diagnosis Engine (Read the Terms First)
Glass Health pairs ambient scribing with a cited differential diagnosis for $0 to $200 a month. We cover the features, pricing and independent studies, plus what most reviews skip: ads on the two cheapest plans, individual terms that authorize model training on PHI, and a BAA you have to opt in to.
NPs Benefit Most From AI Scribes. They Also Carry a Billing Risk Physicians Do Not.
The largest study of ambient AI scribes found advanced practice providers among the biggest beneficiaries. But an NP note also has to establish which billing pathway applies — incident-to, split/shared, or straight 85% — and no scribe writes that for you. With an OIG audit of incident-to payments underway, here is what your note has to say and how to configure your scribe to say it.
The AI Model Card in Your EHR: What HTI-5 Would Delete, and How to Read Yours First
Since January 2025, every certified EHR has had to publish a plain-language disclosure of what its built-in AI was trained on, how it was validated, and what it should never be used for — free, at a public link. ASTP/ONC has proposed deleting that requirement. Here is how to find yours before it goes, and why your standalone AI scribe was never covered by it in the first place.
FDA's Generative AI Device Paper: What It Means for the AI Tools Your Practice Uses (Comments Due Oct. 19)
On August 18, 2026, FDA published its first detailed sketch of how it might regulate generative AI medical devices: a two-axis risk map, clinician-style competency testing, and more postmarket monitoring. It is not guidance and binds no one yet. Here is what it says, where scribes, CDS, patient chatbots and imaging tools land, what the first 'patient-facing LLM' clearance actually covered, and which of the 26 questions clinicians should answer before the October 19 deadline.
Can You Bill for AI? Medicare Already Cut Your Pay for the Efficiency.
The FDA has authorized more than 1,300 AI-enabled medical devices. Medicare pays separately for about ten of them. Meanwhile CMS cut work RVUs 2.5% across most services on the theory that technology already made you more efficient. Here are the AI codes that actually generate payment in 2026, the taxonomy that decides which tools get one, and what the CY 2027 proposed rule would change.